ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 116 filers reported holding ANAPTYSBIO INC in Q3 2023. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,763,182 | -32.0% | 933,362 | -23.0% | 0.00% | 0.0% |
| Q2 2023 | $24,668,637 | -1.4% | 1,212,814 | +5.5% | 0.00% | 0.0% |
| Q1 2023 | $25,022,847 | -63.3% | 1,149,947 | -47.8% | 0.00% | -50.0% |
| Q4 2022 | $68,251,198 | +110.4% | 2,202,362 | +73.2% | 0.00% | 0.0% |
| Q3 2022 | $32,442,000 | +38.3% | 1,271,727 | +10.0% | 0.00% | +100.0% |
| Q2 2022 | $23,464,000 | -1.0% | 1,155,881 | +20.6% | 0.00% | 0.0% |
| Q1 2022 | $23,703,000 | -21.8% | 958,095 | +9.8% | 0.00% | 0.0% |
| Q4 2021 | $30,313,000 | +15.6% | 872,309 | -9.8% | 0.00% | 0.0% |
| Q3 2021 | $26,221,000 | -21.1% | 966,867 | -24.6% | 0.00% | -50.0% |
| Q2 2021 | $33,245,000 | -12.4% | 1,282,110 | -27.2% | 0.00% | 0.0% |
| Q1 2021 | $37,961,000 | +45.2% | 1,761,515 | +44.9% | 0.00% | 0.0% |
| Q4 2020 | $26,135,000 | +48.4% | 1,215,576 | +1.8% | 0.00% | +100.0% |
| Q3 2020 | $17,606,000 | -45.1% | 1,193,596 | -16.9% | 0.00% | -50.0% |
| Q2 2020 | $32,086,000 | +16.1% | 1,436,276 | -26.6% | 0.00% | 0.0% |
| Q1 2020 | $27,632,000 | -12.6% | 1,955,556 | +0.5% | 0.00% | 0.0% |
| Q4 2019 | $31,606,000 | -17.2% | 1,945,009 | +78.3% | 0.00% | -33.3% |
| Q3 2019 | $38,173,000 | -29.3% | 1,090,980 | +13.9% | 0.00% | -25.0% |
| Q2 2019 | $54,022,000 | -26.0% | 957,499 | -4.2% | 0.00% | -33.3% |
| Q1 2019 | $72,979,000 | +2.0% | 999,029 | -11.0% | 0.01% | -14.3% |
| Q4 2018 | $71,567,000 | -35.2% | 1,121,917 | +1.4% | 0.01% | -12.5% |
| Q3 2018 | $110,417,000 | +19.4% | 1,106,732 | -15.0% | 0.01% | 0.0% |
| Q2 2018 | $92,457,000 | -7.2% | 1,301,421 | +35.9% | 0.01% | 0.0% |
| Q1 2018 | $99,666,000 | +53.2% | 957,650 | +48.3% | 0.01% | +60.0% |
| Q4 2017 | $65,036,000 | +1355.6% | 645,734 | +404.8% | 0.01% | – |
| Q3 2017 | $4,468,000 | +149.5% | 127,919 | +70.9% | 0.00% | – |
| Q2 2017 | $1,791,000 | +80.0% | 74,833 | +108.8% | 0.00% | – |
| Q1 2017 | $995,000 | – | 35,837 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,628,678 | $65,033,000 | 13.01% |
| EcoR1 Capital, LLC | 7,521,024 | $186,070,000 | 5.82% |
| GREAT POINT PARTNERS LLC | 700,000 | $17,318,000 | 4.18% |
| Frazier Life Sciences Management, L.P. | 899,700 | $22,259,000 | 1.90% |
| Boxer Capital, LLC | 1,300,000 | $32,162,000 | 1.65% |
| Logos Global Management LP | 300,000 | $7,422,000 | 0.96% |
| Deep Track Capital, LP | 558,782 | $13,824,000 | 0.89% |
| Palo Alto Investors LP | 431,024 | $10,664,000 | 0.82% |
| TCG Crossover Management, LLC | 58,515 | $1,448,000 | 0.58% |
| Rock Springs Capital Management LP | 563,300 | $13,936,000 | 0.35% |